Reset filter
Keywords
Clinical Trial ×
Show more Keywords
Table of contents
  1. 1. Clinical Trial
  2. 2. Routine Documentation
  3. 3. Registry/Cohort Study
  4. 4. Quality Assurance
  5. 5. Data Standard
  6. 6. Patient-Reported Outcome
  7. 7. Medical Specialty
    1. 7.1. Anesthesiology
    1. 7.2. Dermatology
    1. 7.3. ENT
    1. 7.4. Geriatrics
    1. 7.5. Gynecology/Obstetrics
    1. 7.6. Internal Medicine
      1. Hematology
      1. Infectious Diseases
      1. Cardiology/Angiology
      1. Pneumology
      1. Gastroenterology
      1. Nephrology
      1. Endocrinology/Metabolic Diseases
      1. Rheumatology
    1. 7.7. Neurology
    1. 7.8. Ophthalmology
    1. 7.9. Palliative Care
    1. 7.10. Pathology/Forensics
    1. 7.11. Pediatrics
    1. 7.12. Psychiatry/Psychosomatics
    1. 7.13. Radiology
    1. 7.14. Surgery
      1. General/Visceral Surgery
      1. Neurosurgery
      1. Plastic Surgery
      1. Thoracic Surgery
      1. Trauma/Orthopedics
      1. Vascular Surgery
    1. 7.15. Urology
    1. 7.16. Dental Medicine/OMS
Selected data models

You must log in to select data models for download or further analysis.

1907 Search results.
Relevance Rating New first Old first

Endpoint Myocardial infarction GSK study Chronic Coronary Heart Disease NCT00799903

- 1/3/18 - 1 form, 3 itemgroups, 48 items, 1 language
Itemgroups: Investigator Section, CEC Section, CEC STATUS
Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Endpoint Myocardial infarction - Repeating form (Scheduled visits)

ECG Evidence of myocardial ischemia/infarction GSK study Chronic Coronary Heart Disease NCT00799903

- 1/3/18 - 1 form, 1 itemgroup, 13 items, 1 language
Itemgroup: ECG Evidence of myocardial ischemia/infarction
Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: ECG Evidence of myocardial ischemia/infarction - Repeating form (Scheduled visits)

Eligibility Coronary Heart Disease NCT02509013

- 3/12/19 - 1 form, 2 itemgroups, 14 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Prevalence of Chronic Kidney Disease and Its Association With Clinical Outcome in Patients With Coronary Heart Disease; ODM derived from: https://clinicaltrials.gov/show/NCT02509013

Eligibility Coronary Heart Disease NCT02435797

- 3/12/19 - 1 form, 2 itemgroups, 16 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Effect of Nicorandil for the Patients of Acute ST Segment Elevation Myocardial Infarction; ODM derived from: https://clinicaltrials.gov/show/NCT02435797

Eligibility Coronary Heart Disease NCT02389153

- 3/12/19 - 1 form, 2 itemgroups, 18 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Feasability of Collaborative Care in the Secondary Prevention of Coronary Heart Disease; ODM derived from: https://clinicaltrials.gov/show/NCT02389153

Eligibility Coronary Heart Disease NCT02044250

- 3/12/19 - 1 form, 2 itemgroups, 16 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- EXtended Antiplatelet Monotherapy (HOST-EXAM); ODM derived from: https://clinicaltrials.gov/show/NCT02044250

Eligibility Coronary Heart Disease NCT01735656

- 3/12/19 - 1 form, 2 itemgroups, 18 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Comparison of Double Kissing Culotte Stenting With Double Kissing Crush Stenting for True Bifurcation Lesions; ODM derived from: https://clinicaltrials.gov/show/NCT01735656

Eligibility Coronary Heart Disease NCT01942044

- 12/16/18 - 1 form, 2 itemgroups, 9 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Relation Among Shear Stress Distribution, Stent Design, and Subsequent Vessel Healing After Drug-eluting Stent Implantation (SHEAR DES); ODM derived from: https://clinicaltrials.gov/show/NCT01942044

Eligibility Coronary Heart Disease NCT01654653

- 2/4/18 - 1 form, 2 itemgroups, 11 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Efficacy and Safety of Hypertonic Sodium Lactate Solution Compared With 6% HES Solution in CABG Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01654653

Eligibility Coronary Heart Disease NCT01021930

- 2/4/18 - 1 form, 2 itemgroups, 21 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Comparison of Diabetes Mellitus and Non-diabetes Mellitus Patients for DES Surface COVERage by OCT; ODM derived from: https://clinicaltrials.gov/show/NCT01021930

Eligibility Coronary Heart Disease NCT00959972

- 2/4/18 - 1 form, 2 itemgroups, 9 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Varenicline Versus Transdermal Nicotine Patch for Smoking Cessation in Patients With Coronary Heart Disease; ODM derived from: https://clinicaltrials.gov/show/NCT00959972

Eligibility Coronary Heart Disease NCT00950339

- 2/4/18 - 1 form, 2 itemgroups, 15 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Platelet Inhibitory Effect of Clopidogrel in Patients Treated With Omeprazole, Pantoprazole, or Famotidine; ODM derived from: https://clinicaltrials.gov/show/NCT00950339

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial